An experimental treatment combining tirzepatide with a second hormone-based medicine has produced greater weight loss and reductions in blood glucose than tirzepatide alone in people with type 2 ...
People with obesity or overweight and type 2 diabetes lost up to 13.1% of their body weight with survodutide over 76 weeks.
Researchers identified 624 common genetic signals associated with body fat and BMI during childhood. The results suggest childhood and adult obesity overlap biologically but are not simply the same ...
An oral drug called danegaptide showed early biological activity in people with non-proliferative diabetic retinopathy. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results